Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.

Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, Hansell DM, du Bois RM, Wells AU.

Eur Respir J. 2010 Apr;35(4):830-6. doi: 10.1183/09031936.00155108. Epub 2009 Oct 19.

2.

Epidemiology of interstitial lung diseases in Greece.

Karakatsani A, Papakosta D, Rapti A, Antoniou KM, Dimadi M, Markopoulou A, Latsi P, Polychronopoulos V, Birba G, Ch L, Bouros D; Hellenic Interstitial Lung Diseases Group.

Respir Med. 2009 Aug;103(8):1122-9. doi: 10.1016/j.rmed.2009.03.001. Epub 2009 Apr 3.

3.

Impaired aortic elastic properties in patients with systemic sarcoidosis.

Moyssakis I, Gialafos E, Tentolouris N, Floudas CS, Papaioannou TG, Kostopoulos Ch, Latsi P, Vaiopoulos G, Votteas V, Rapti A.

Eur J Clin Invest. 2008 Feb;38(2):82-9. doi: 10.1111/j.1365-2362.2007.01906.x.

PMID:
18226041
4.

Daily cyclophosphamide for scleroderma: are patients with the most to gain underrepresented in this trial?

Wells AU, Latsi P, McCune WJ.

Am J Respir Crit Care Med. 2007 Nov 15;176(10):952-3. No abstract available.

PMID:
17984310
5.

Non-invasive measurement of the mean alveolar O(2) tension from the oxygen uptake versus tidal volume curve.

Jordanoglou J, Latsi P, Chroneou A, Koulouris NG.

Acta Physiol (Oxf). 2007 Oct;191(2):161-8.

PMID:
17848173
6.

Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-alpha gene: their association with obstructive pulmonary disease in Greek patients.

Papatheodorou A, Latsi P, Vrettou C, Dimakou A, Chroneou A, Makrythanasis P, Kaliakatsos M, Orfanidou D, Roussos C, Kanavakis E, Tzetis M.

Clin Biochem. 2007 Aug;40(12):843-50. Epub 2007 Apr 19.

PMID:
17509552
7.

Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis.

Antoniou KM, Nicholson AG, Dimadi M, Malagari K, Latsi P, Rapti A, Tzanakis N, Trigidou R, Polychronopoulos V, Bouros D.

Eur Respir J. 2006 Sep;28(3):496-504. Epub 2006 Apr 12.

8.

Microscopic polyangiitis complicated by the development of prostate cancer and flutamide-induced hepatitis.

Papaioannides D, Korantzopoulos P, Bouropoulos C, Latsi P, Fotinou M, Orphanidou D.

Int Urol Nephrol. 2005;37(3):515-20.

PMID:
16307333
9.

Tuberculous effusion: ADA activity correlates with CD4+ cell numbers in the fluid and the pleura.

Gaga M, Papamichalis G, Bakakos P, Latsi P, Samara I, Koulouris NG, Alchanatis N, Orphanidou D.

Respiration. 2005 Mar-Apr;72(2):160-5.

PMID:
15824526
10.

Disseminated tuberculosis complicating anti-TNF-alpha treatment.

Dimakou K, Papaioannides D, Latsi P, Katsimboula S, Korantzopoulos P, Orphanidou D.

Int J Clin Pract. 2004 Nov;58(11):1052-5.

PMID:
15605672
11.

Systemic lupus erythematosus developing in a patient with pulmonary sarcoidosis.

Papaioannides D, Korantzopoulos P, Latsi P, Orphanidou D.

Joint Bone Spine. 2004 Sep;71(5):442-4. No abstract available.

PMID:
15474401
12.

Unevenness of ventilation assessed by the expired CO(2) gas volume versus V(T) curve in asthmatic patients.

Koulouris NG, Latsi P, Stavrou E, Chroneou A, Gaga M, Jordanoglou J.

Respir Physiol Neurobiol. 2004 Jun 25;140(3):293-300.

PMID:
15186790
13.

Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.

Papaioannides D, Fotinou M, Korantzopoulos P, Latsi P, Sinapidis D, Akritidis N, Orphanidou D.

Med Sci Monit. 2004 Jan;10(1):CS5-7.

PMID:
14704637
14.

Evaluation and management of alveolitis and interstitial lung disease in scleroderma.

Latsi PI, Wells AU.

Curr Opin Rheumatol. 2003 Nov;15(6):748-55. Review.

PMID:
14569205
15.

BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.

Veeraraghavan S, Latsi PI, Wells AU, Pantelidis P, Nicholson AG, Colby TV, Haslam PL, Renzoni EA, du Bois RM.

Eur Respir J. 2003 Aug;22(2):239-44.

16.

Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis.

Latsi P, Pantelidis P, Vassilakis D, Sato H, Welsh KI, du Bois RM.

Respir Res. 2003;4:6. Epub 2003 Jun 27.

17.

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU.

Am J Respir Crit Care Med. 2003 Sep 1;168(5):531-7. Epub 2003 Jun 5.

PMID:
12791580
18.

Noninvasive measurement of mean alveolar carbon dioxide tension and Bohr's dead space during tidal breathing.

Koulouris NG, Latsi P, Dimitroulis J, Jordanoglou B, Gaga M, Jordanoglou J.

Eur Respir J. 2001 Jun;17(6):1167-74.

19.

Optimal duration of chemotherapy in small cell lung cancer: a randomized study of 4 versus 6 cycles of cisplatin-etoposide.

Veslemes M, Polyzos A, Latsi P, Dimitroulis J, Stamatiadis D, Dardoufas C, Rasidakis A, Katsilambros N, Jordanoglou J.

J Chemother. 1998 Apr;10(2):136-40.

PMID:
9603640
20.

An immunocytochemical study of ras and myc oncoproteins and EGFr expression in pleural effusion smears.

Athanassiadou P, Orphanidou D, Kyrkou K, Latsi P, Petrakakou E, Rasidakis A, Jordanoglou J.

Oncol Rep. 1996 May;3(3):549-52.

PMID:
21594410
21.

Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.

Orphanidou D, Gaga M, Rasidakis A, Dimakou K, Toumbis M, Latsi P, Pandalos J, Christacopoulou J, Jordanoglou J.

Respir Med. 1996 Feb;90(2):95-8.

22.

Recurrent respiratory papillomatosis with malignant transformation in a young adult.

Orphanidou D, Dimakou K, Latsi P, Gaga M, Toumbis M, Rasidakis A, Jordanoglou J.

Respir Med. 1996 Jan;90(1):53-5.

23.

Outcome of patients with brain metastases after combined modality therapy in small cell lung cancer (SCLC): a retrospective study.

Veslemes M, Polyzos A, Latsi P, Dimitroulis J, Dimakou K, Jordanoglou J.

J Chemother. 1995 Oct;7(5):460-2.

PMID:
8596133

Supplemental Content

Support Center